Red Light Nasal Therapy Device + RespicoviX

Technical specifications:

• Light wavelength: 630 nm ± 20 nm (red light)
• Radiation intensity: 12 mW ± 3 mW
• Technology: low-intensity red LED light technology
• Additional program: RespiCoviX radionics / energy-information model biopattern program
• Power: rechargeable / USB
• Area of use: nasal cavity and surrounding sinus areas
• Recommended use: 1–2 times per day, for 10–15 minutes

Description

The Red Light Nasal Device is a non-invasive device designed for comfort and wellbeing care of the nasal area. It uses 630 nm ± 20 nm red LED light and an additional BioMind RespiCoviX radionics / energy-information model program.

The device emits 630 nm ± 20 nm red LED light at a specified intensity of 12 mW ± 3 mW. The scientific literature on red light and photobiomodulation discusses their relationship to various cellular processes, including mitochondrial and ATP metabolism. This information describes the general scientific context of photobiomodulation and is not confirmation of the physiological or clinical effect of this specific device.

The device additionally uses the BioMind RespiCoviX biopattern program. In the context of the radionics / energy-information model, it is associated with informational themes of the nose, airways, and energetic balance. The RespiCoviX program is separate from the physical operation of the LED light and is not attributed any physiological effect on the nasal mucosa, airways, viruses, the immune system, or other biological processes.

The device is intended for comfort and wellbeing care of the nasal area. The physical operation of the LED light and the RespiCoviX radionics / energy-information model program are treated as separate components in this description.

To understand how the product works, it is recommended to take the radionics course.

Disclaimer

This product is presented as a device for comfort and wellbeing care of the nasal area. It is not intended to diagnose, treat, cure, or prevent any health condition. If you have health concerns, consult a doctor or other qualified healthcare professional before use.

The scientific information on this page about intranasal red light and photobiomodulation technology in general is not proof of the clinical effectiveness of this specific device.

The field of radionics and the informational field has been the subject of scientific research for over a century. In recent years the number of publications has been growing (e.g. Rubik B. et al., “Biofield Science and Healing: History, Terminology, and Concepts”, Global Advances in Health and Medicine, 2015), but existing studies are not yet sufficient for definitive clinical conclusions.

Usage Recommendations

Before use, make sure the device is fully charged. Gently insert the light applicators into the nostrils so that they rest comfortably against the mucosa.

• Turn on the device and use it for 10–15 minutes.
• You may repeat the procedure 1–2 times per day, depending on need.
• During use, breathe normally and follow the manufacturer’s instructions for use.
• After use, wipe the applicators with a disinfecting wipe or a clean cloth.

The device is designed for comfort and wellbeing care of the nasal area.

Why Choose This Device?

The device uses 630 nm ± 20 nm red LED light and is designed for comfort and wellbeing care of the nasal area. The additional RespiCoviX program is used in the context of the radionics / energy-information model and is separate from the physical operation of the LED light.

What the scientific literature shows about intranasal photobiomodulation (in general, not about this specific product):
The information below describes intranasal photobiomodulation technologies and protocols evaluated in specific scientific studies and systematic reviews. It is not proof of the clinical effectiveness of this specific Biomind device.

• Individual clinical studies and systematic reviews have evaluated intranasal red or near-infrared light technologies in the context of allergic rhinitis symptoms. Some of these studies found statistically significant changes in the symptoms evaluated. These results apply to the specific devices and protocols used in the studies.
• The scientific literature has also examined the use of photobiomodulation in the context of chronic rhinosinusitis. This data is not proof of the effectiveness of this specific Biomind device.

Important: This device uses 630 nm ± 20 nm LED light, but this specific Biomind product has not been separately clinically studied. The information above summarizes the general scientific literature on intranasal red light / photobiomodulation technology overall and is not confirmation of the clinical effectiveness of this specific device.

Sources:

• „Low-Level Laser Therapy for Allergic Rhinitis: A Systematic Review and Meta-Analysis” — PMCID: PMC11370728
• „The effectiveness of low-level laser therapy for chronic rhinosinusitis: A systematic review and meta-analysis” — PMID: 41239066
• „Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo-Controlled Randomized Clinical Trial” — PMID: 39828891
• „Effect of Red Light Rhinophototherapy on Nasal Patency in Patients with Allergic Rhinitis” — PMCID: PMC6311790